Kamada Ltd.
NASDAQ: KMDA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Amir London
- Employees
- 420
- Headquarters
- Rehovot, Israel
- IPO year
- 2013
- Market cap
- $411.6M
- Website
- https://www.kamada.com
Loading KMDA…
Loading profile data…Frequently asked questions about KMDA
What does Kamada Ltd. (KMDA) do?
Kamada Ltd. is a biopharmaceutical firm focused on developing, manufacturing, and distributing protein therapeutics derived from human plasma. The company operates through two core business areas: its proprietary product segment and its distribution division. Its own manufactured portfolio includes KAMRAB/KEDRAB for rabies prevention, CYTOGAM to...
Where does KMDA trade?
Kamada Ltd. (KMDA) trades on the NASDAQ Global Select.
What sector is KMDA in?
Kamada Ltd. (KMDA) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Kamada Ltd.?
Amir London is the chief executive officer of Kamada Ltd. (KMDA).
Where is Kamada Ltd. headquartered?
Kamada Ltd. is headquartered in Israel.
Does KMDA pay a dividend?
Yes — Kamada Ltd. (KMDA) paid a trailing twelve-month dividend of USD 0.25 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did KMDA go public?
Kamada Ltd. (KMDA) completed its initial public offering in 2013.